Reactions 1680, p128 - 2 Dec 2017 Marrow suppression and mucosal ulceration: case report A 29-year-old woman developed marrow suppression and mucosal ulceration during treatment with epirubicin and ifosfamide. The woman was scheduled to receive four cycles of adjuvant chemotherapy with ifosfamide and epirubicin [routes and dosages not stated] for pancreatic liposarcoma. The first cycle of the chemotherapy was initiated in July 2015. However, she developed severe chemotherapy associated adverse reactions (ADRs) such as mucosal ulceration and marrow suppression [duration of treatments to reactions onset and outcomes not stated]. The ADRs resulted in unwillingness to continue the medications. But, the woman decline to change her first-line chemotherapeutic treatment. She later had recurrence of liposarcoma and the chemotherapy was switched to apatinib. Author comment: ’’[T]he patient experienced severe chemotherapy related adverse reactions such as marrow suppression and mucosal ulceration, which resulted the hesitation of the medication use.’’ Han T, et al. Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review. Cancer Biology and Therapy 18: 635-639, No. 9, 2017. Available from: URL: http:// doi.org/10.1080/15384047.2017.1345394 - China 803285409 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera